• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浅表膀胱肿瘤膀胱内卡介苗治疗的经验

Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors.

作者信息

Herr H W, Pinsky C M, Whitmore W F, Sogani P G, Oettgen H F, Melamed M R

出版信息

Urology. 1985 Feb;25(2):119-23. doi: 10.1016/0090-4295(85)90525-4.

DOI:10.1016/0090-4295(85)90525-4
PMID:3881870
Abstract

Between March, 1978, and July, 1981, 86 patients with polychronotopic superficial papillary bladder tumors and concurrent carcinoma in situ were randomized to receive either transurethral resection alone (43) or TUR plus BCG (43). The results indicate that BCG is not only active in preventing recurrences of new tumors but also effective for the diffuse, flat carcinoma in situ.

摘要

在1978年3月至1981年7月期间,86例患有多灶性浅表乳头状膀胱肿瘤并伴有原位癌的患者被随机分为两组,一组仅接受经尿道切除术(43例),另一组接受经尿道切除术加卡介苗治疗(43例)。结果表明,卡介苗不仅对预防新肿瘤的复发有效,而且对弥漫性扁平原位癌也有疗效。

相似文献

1
Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors.浅表膀胱肿瘤膀胱内卡介苗治疗的经验
Urology. 1985 Feb;25(2):119-23. doi: 10.1016/0090-4295(85)90525-4.
2
Effect of intravesical Bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder.膀胱内卡介苗(BCG)对膀胱原位癌的作用。
Cancer. 1983 Apr 1;51(7):1323-6. doi: 10.1002/1097-0142(19830401)51:7<1323::aid-cncr2820510724>3.0.co;2-2.
3
Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder.膀胱内卡介苗对膀胱扁平原位癌的长期影响。
J Urol. 1986 Feb;135(2):265-7. doi: 10.1016/s0022-5347(17)45604-7.
4
Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup.卡介苗治疗浅表性膀胱癌:10年随访
J Urol. 1992 Apr;147(4):1020-3. doi: 10.1016/s0022-5347(17)37452-9.
5
Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.高危浅表性膀胱癌的再次经尿道切除术可改善对卡介苗治疗的初始反应。
J Urol. 2005 Dec;174(6):2134-7. doi: 10.1097/01.ju.0000181799.81119.fc.
6
Retrospective study of efficacy of intravesical BCG alone in treatment of superficial bladder cancer.卡介苗膀胱灌注单药治疗浅表性膀胱癌疗效的回顾性研究
Urology. 1986 Sep;28(3):173-5. doi: 10.1016/0090-4295(86)90036-1.
7
Intravesical Bacillus Calmette Guerin therapy in patients with superficial bladder tumor.卡介苗膀胱灌注治疗浅表性膀胱肿瘤患者
Prog Clin Biol Res. 1989;303:375-81.
8
BCG therapy of superficial bladder tumors.浅表性膀胱肿瘤的卡介苗治疗。
Prog Clin Biol Res. 1989;303:369-74.
9
[Treatment of superficial tumors of the bladder with bacillus Calmette-Guérin].[卡介苗治疗膀胱浅表肿瘤]
J Urol (Paris). 1986;92(1):33-8.
10
Single course versus maintenance bacillus Calmette-Guerin therapy for superficial bladder tumors: a prospective, randomized trial.卡介苗单疗程与维持治疗浅表性膀胱肿瘤的前瞻性随机试验
J Urol. 1987 Aug;138(2):295-8. doi: 10.1016/s0022-5347(17)43125-9.

引用本文的文献

1
Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Full-text.加拿大泌尿外科协会非肌层浸润性膀胱癌管理指南 - 全文
Can Urol Assoc J. 2021 Aug;15(8):E424-E460. doi: 10.5489/cuaj.7367.
2
Can we treat bladder cancer with intravesical Bacillus Calmette-Guerin in patients with prior tuberculosis infection? A population-based cohort study.对于既往结核感染患者,能否采用膀胱内卡介苗治疗膀胱癌?一项基于人群的队列研究。
BMC Urol. 2020 Jul 8;20(1):91. doi: 10.1186/s12894-020-00642-1.
3
CUA guidelines on the management of non-muscle invasive bladder cancer.
加拿大泌尿外科协会非肌层浸润性膀胱癌管理指南。
Can Urol Assoc J. 2015 Sep-Oct;9(9-10):E690-704. doi: 10.5489/cuaj.3320. Epub 2015 Oct 13.
4
Prophylactic effects of Bacille Calmette-Guérin intravesical instillation therapy: time period-related comparison between Japan and Western countries.卡介苗膀胱内灌注治疗的预防作用:日本与西方国家的时间相关比较。
Curr Urol Rep. 2014 Jan;15(1):374. doi: 10.1007/s11934-013-0374-1.
5
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.研究观察:美国食品和药物管理局批准的用于癌症治疗的 Toll 样受体激动剂。
Oncoimmunology. 2012 Sep 1;1(6):894-907. doi: 10.4161/onci.20931.
6
Update on intravesical agents for non-muscle-invasive bladder cancer.非肌层浸润性膀胱癌膀胱内灌注药物的最新进展
Immunotherapy. 2010 May;2(3):381-92. doi: 10.2217/imt.10.1.
7
Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy.加拿大非肌肉浸润性膀胱癌治疗指南:聚焦膀胱内治疗
Can Urol Assoc J. 2010 Jun;4(3):168-73. doi: 10.5489/cuaj.10051.
8
Update on the management of non-muscle invasive bladder cancer.非肌肉浸润性膀胱癌管理的最新进展
Can Urol Assoc J. 2010 Feb;4(1):56-64. doi: 10.5489/cuaj.777.
9
Intravesical therapy for urothelial carcinoma of the urinary bladder: a critical review.膀胱尿路上皮癌的膀胱内治疗:批判性评价。
Int Braz J Urol. 2009 Nov-Dec;35(6):640-50; discussion 651. doi: 10.1590/s1677-55382009000600002.
10
Study on enhancement of fibronectin-mediated bacillus Calmette-Guérin attachment to urinary bladder wall in rabbits.增强纤连蛋白介导的卡介苗黏附兔膀胱壁的研究
World J Urol. 2007 Oct;25(5):525-9. doi: 10.1007/s00345-007-0198-z. Epub 2007 Jul 13.